SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Hindocha S, McGrouther DA, Bayat A. Epidemiological evaluation of Dupuytren's disease incidence and prevalence rates in relation to etiology. Hand (N Y) 2009; 4: 25669.
  • 2
    Khan AA, Rider OJ, Jayadev CU, Heras-Palou C, Giele H, Goldacre M. The role of manual occupation in the aetiology of Dupuytren's disease in men in England and Wales. J Hand Surg Br 2004; 29: 124.
  • 3
    Rayan GM. Dupuytren disease: anatomy, pathology, presentation, and treatment. J Bone Joint Surg Am 2007; 89: 18998.
  • 4
    Tubiana R, Michon J. Classification de la maladie de Dupuytren. Mem Acad Chir (Paris) 1961; 87: 8867.
  • 5
    Badalamente MA, Hurst LC, Hentz VR. Collagen as a clinical target: nonoperative treatment of Dupuytren's disease. J Hand Surg Am 2002; 27: 78898.
  • 6
    Van Rijssen AL, Gerbrandy FS, Ter Linden H, Klip H, Werker PM. A comparison of the direct outcomes of percutaneous needle fasciotomy and limited fasciectomy for Dupuytren's disease: a 6-week follow-up study. J Hand Surg Am 2006; 31: 71725.
  • 7
    Badalamente MA, Hurst LC. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture. J Hand Surg Am 2007; 32: 76774.
  • 8
    Hurst LC, Badalamente MA, Hentez VR, Hotchkiss RN, Kaplan FT, Meals RA, et al. Injectable collagenase clostridium histolyticum for Dupuytren's contracture. N Engl J Med 2009; 361: 96879.
  • 9
    Sinha R, Cresswell TR, Mason R, Chakrabarti I. Functional benefit of Dupuytren's surgery. J Hand Surg Br 2002; 27: 37881.
  • 10
    Draviaraj KP, Chakrabarti I. Functional outcome after surgery for Dupuytren's contracture: a prospective study. J Hand Sur Am 2004; 29: 8048.
  • 11
    Dias JJ, Braybrooke J. Dupuytren's contracture: an audit of the outcomes of surgery. J Hand Surg Br 2006; 31: 51421.
  • 12
    Zyluk A, Jagielski W. The effect of the severity of the Dupuytren's contracture on the function of the hand before and after surgery. J Hand Surg Eur Vol 2007; 32: 3269.
  • 13
    Johnston P, Larson D, Clark IM, Chojnowski AJ. Metalloproteinase gene expression correlates with clinical outcome in Dupuytren's disease. J Hand Surg Am 2008; 33: 11607.
  • 14
    Degreef I, Vererfve PB, De Smet L. Effect of severity of Dupuytren contracture on disability. Scand J Plast Reconstr Surg Hand Surg 2009; 43: 412.
  • 15
    Chung KC, Pillsbury MS, Walters MR, Hayward RA. Reliability and validity testing of the Michigan Hand Outcomes Questionnaire. J Hand Surg Am 1998; 23: 57587.
  • 16
    Chung KC, Hamill JB, Walters MR, Hayward RA. The Michigan Hand Outcomes Questionnaire (MHQ): assessment of responsiveness to clinical change. Ann Plast Surg 1999; 42: 61922.
  • 17
    Townley WA, Baker R, Sheppard N, Grobbelaar AO. Dupuytren's contracture unfolded. BMJ 2006; 332: 397400.
  • 18
    Roush TF, Stern PJ. Results following surgery for recurrent Dupuytren's disease. J Hand Surg Am 2000; 25: 2916.
  • 19
    Engstrang C, Boren L, Liedberg GM. Evaluation of activity limitation and digital extension in Dupuytren's contracture three months after fasciectomy and hand therapy interventions. J Hand Ther 2009; 22: 216.
  • 20
    Schuind FA, Mouraux D, Robert C, Brassinne E, Remy P, Salvia P, et al. Functional and outcome evaluation of the hand and wrist. Hand Clin 2003; 19: 3619.
  • 21
    Duruoz MT, Poiraudeau S, Fermanian J, Menkes CJ, Amor B, Dougados M, et al. Development and validation of a rheumatoid hand functional scale that assesses functional handicap. J Rheumatol 1996; 23: 116772.
  • 22
    Streiner DL, Norman GR. Health measurement scales: a practical guide to their development and use. Oxford: Oxford University Press; 2003.
  • 23
    US Department of Health and Human Services FDA Center for Drug Evaluation and Research, FDA Center for Biologics Evaluation and Research, and FDA Center for Devices and Radiological Health. Guidance for industry. Patient-reported outcome measures: use in medical product development to support labeling claims: final guidance. 2009. URL: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/UCM193282.pdf.
  • 24
    Fermanian J. Validation of assessment scales in physical medicine and rehabilitation: how are psychometric properties determined? Ann Readpat Med Phys 2005; 48: 2817.
  • 25
    Hudak PL, Amadio PC, Bombardier C, for the Upper Extremity Collaborative Group (UECG). Development of an upper extremity outcome measure: the DASH (disabilities of the arm, shoulder, and hand). Am J Ind Med 1996; 29: 6028.
  • 26
    Fayad F, Lefevre-Colau MM, Mace Y, Fermanian J, Mayoux-Benhamou A, Roren A, et al. Validation of the French version of the arm, shoulder and hand questionnaire (F-DASH). Joint Bone Spine 2008; 75: 195200.
  • 27
    Zigmond AS, Snaith RP. The hospital anxiety and depression rate. Acta Psychiatr Scand 1983; 67: 36170.
  • 28
    Razavi D, Delvaux N, Farvacques C, Robaye E. Screening for adjustment disorders and major depressive disorders in cancer in-patients. Br J Psychiatry 1990; 156: 7983.
  • 29
    Cohen J. Statistical power analysis for the behavioral sciences. 2nd ed. Mahwah (NJ): Lawrence Erlbaum Associates; 1988.
  • 30
    Feinstein AR, Josephy BR, Wells CK. Scientific and clinical problems in indexes of functional disability. Ann Intern Med 1986; 105: 41320.
  • 31
    Pap G, Angst F, Herren D, Schwyzer HK, Simmen BR. Evaluation of wrist and hand handicap and postoperative outcome in rheumatoid arthritis. Hand Clin 2003; 19: 47181.
  • 32
    Dziedzic KS, Thomas E, Hay EM. A systematic search and critical review of measures of disability for use in a population survey of hand osteoarthritis. Osteoarthritis Cartilage 2005; 13: 112.
  • 33
    Savas S, Koroglu BK, Koyuncuoplu HR, Uzar E, Celik H, Tamer NM. The effects of the diabetes related soft tissue hand lesions and the reduced hand strength on functional disability of hand in type 2 diabetic patients. Diabetes Res Clin Pract 2007; 77: 7783.
  • 34
    Dias JJ, Bhowall B, Wildin CJ, Thompson JR. Assessing the outcome of disorders of the hand: is the patient evaluation measure reliable, valid, responsive and without bias? J Bone Surg Br 2001; 83: 23540.
  • 35
    Poiraudeau S, Chevalier X, Conrozier T, Flippo RM, Liote F, Noel E, et al. Reliability, validity, and sensitivity to change of the Cochin hand functional disability scale in hand osteoarthritis. Osteoarthritis Cartilage 2001; 9: 5707.
  • 36
    Brod M, Tesler LE, Christensen TL. Qualitative research and content validity: developing best practices based on science and experience. Qual Life Res 2009; 18: 126378.
  • 37
    Badois FJ, Lermusiaux JL, Masse C, Kuntz D. Non-surgical treatment of Dupuytren disease using needle fasciotomy. Rev Rhum Ed Fr 1993; 60: 80813. In French.
  • 38
    Frost MH, Reeve BB, Liepa AM, Stauffer JW, Hays RD. Mayo/FDA patient-reported outcomes consensus meeting group: what is sufficient evidence for reliability and validity of patient-reported outcome measure? Value Health 2007; 10 Suppl: S94105.
  • 39
    Terwee CB, Bot SD, de Boer MR, van der Windt DA, Knol DL, Dekker J, et al. Quality criteria were proposed for measurement properties of health status questionnaires. J Clin Epidemiol 2007; 60: 3442.